Sprouty1 is a broad mediator of cellular senescence |
2024 |
Anerillas, Carlos; Perramon Güell, Aida; Altés, Gisela; Cuesta, Sara; Vaquero, Marta; Olomi, Anna; Rodriguez Barrueco, Ruth; Llobet Navàs, David; Egea, Joaquim; Dolcet, Xavi; Yeramian, Andrée, Encinas |
Article d'investigació |
Oxidative-stress-induced FAK activation contributes to uterine serous carcinoma aggressiveness. |
2023 |
Lopez Mejia. I.C.; Pijuan, J.; Navaridas, R.; Santacana, M.; Gatius, S.; Velasco, A.; Castellà, G.; Panosa, A.; Cabiscol, E.; Pinyol, M.; Coll, L.; Bonifaci, N.; Plata Peña, L.; Vidal, A.; Villanueva, |
Article d'investigació |
In Vivo Intra-Uterine Delivery of TAT-Fused Cre Recombinase and CRISPR/Cas9 Editing System in Mice Unveil Histopathology of Pten/p53-Deficient Endometrial Cancers |
2023 |
Navaridas, R.; Vidal Sabanés, M.; Ruiz Mitjana, A.; Altés, G.; Perramon Güell, A.; Yeramian, A.; Egea, J.; Encinas, M.; Gatius, S.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
PKN1 Kinase: A Key Player in Adipocyte Differentiation and Glucose Metabolism |
2023 |
Herrerías González, Fernando; Yeramian, Andrée; Baena Fustegueras, Juan Antonio; Bueno, Marta; Fleitas, Catherine, de la Fuente, Maricruz; Serrano, José C.E.; Granado Serrano, Ana; Santamaría, Maite; |
Article d'investigació |
Metformin exhibits antineoplastic effects on Pten-deficient endometrial cancer by interfering with TGF-β and p38/ERK MAPK signalling |
2023 |
Ruiz Mitjana, Anna; Vidal Sabanés, Maria; Navaridas, Raúl; Perramon Güell, Aida; Yeramian, Andree; Nicholson Sabaté, Nathan; Egea, Joaquim; Encinas, Mario; Matias Guiu, Xavier; Dolcet, Xavier |
Article d'investigació |
Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer |
2022 |
Gatius, S.; Jove, M.; Megino Luque, C.; Albertí Valls, M.; Yeramian, A.; Bonifaci, N.; Piñol, M.; Santacana, M.; Pradas, I.; Llobet Navas, D.; Pamplona, R.; Matías Guiu, X.; Eritja, N. |
Article d'investigació |
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes. |
2022 |
Altés, G.; Vaquero, M.; Cuesta, S.; Anerillas, C.; Macià, A.; Espinet, C.; Ribera, J.; Bellusci, S.; Klein, O.D.; Yeramian, A.; Dolcet, X.; Egea, J.; Encinas, M. |
Article d'investigació |
Lack of extracellular matrix switches TGF-β induced apoptosis of endometrial cells to epithelial to mesenchymal transition |
2022 |
Ruiz Mitjana, A.; Navaridas, R.; Vidal Sabanés, M.; Perramon Güell, A.; Yeramian, A.; Felip, I.; Eritja, N.; Egea, J.; Encinas, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
Randomized clinical trial to evaluate the morphological changes in the adventitial vasa vasorum density and biological markers of endothelial dysfunction in subjects with moderate obesity undergoing a |
2021 |
Sánchez, E.; Santos, M.D.; Nuñez Garcia, M.; Bueno, M.; Sajoux, I.; Yeramian, A.; Lecube, A. |
Article d'investigació |
Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS project. |
2019 |
Sánchez, E.; Lecube, A.; Betriu, A.; Hernández, C.; López Cano, C.; Gutiérrez Carrasquilla, L.; Kerkeni, M.; Yeramian, A.; Purroy, F.; Pamplona, R.; Farràs, C.; Fernández, E.; Barbé, F.; Simó, R. |
Article d'investigació |
Sympathetic Hyperactivity and Sleep Disorders in Individuals With Type 2 Diabetes. |
2019 |
López Cano, C.; Gutiérrez Carrasquilla, L.; Sánchez, E.; González, J.; Yeramian, A.; Martí, R.; Hernández, M.; Cao, G.; Ribelles, M.; Gómez, X.; Barril, S.; Barbé, F.; Hernández, C.; Simó, R.; Lecube |
Article d'investigació |
The influence of sleep apnea syndrome and intermittent hypoxia in carotid adventitial vasa vasorum. |
2019 |
López Cano, C.; Rius, F.; Sánchez, E.; Gaeta, AM.; Betriu, À.; Fernández, E.; Yeramian, A.; Hernández, M.; Bueno, M.; Gutiérrez Carrasquilla, L.; Dalmases, M.; Lecube, A. |
Article d'investigació |
Skin Autofluorescence Measurement in Subclinical Atheromatous Disease: Results from the ILERVAS Project. |
2019 |
Sánchez, E.; Betriu, À.; Yeramian, A.; Fernández, E.; Purroy, F.; Sánchez de la Torre, M.; Pamplona, R.; Miquel, E.; Kerkeni, M.; Hernández, C.; Simó, R.; Lecube, A.; Hernández, M.; Rius, F.; Polanco, |
Article d'investigació |
Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers. |
2018 |
Nager M, Sallán MC, Visa A, Pushparaj C, Santacana M, Macià A, Yeramian A, Cantí C & Herreros J. |
Article d'investigació |
Influence of Morbid Obesity and Bariatric Surgery Impact on the Carotid Adventitial Vasa Vasorum Signal |
2018 |
Rius, F.; Sánchez, E.; Betriu, À.; Baena Fustegueras, J.A.; Yeramian, A.; Vidal, T.; Hernández, M.; López Cano, C.; Bueno, M.; Gutiérrez Carrasquilla, L.; Herrerías, F.; de la Fuente, M.C.; Fernández, |
Article d'investigació |
Endometrial Carcinoma: Specific Targeted Pathways. |
2017 |
Eritja, N.; Yeramian, A.; Chen, B.J.; Llobet Navas, D.; Ortega, E.; Colas, E.; Abal, M.; Dolcet, X.; Reventos, J.; Matias Guiu, X. |
Review |
A Smad3-PTEN regulatory loop controls proliferation and apoptotic responses to TGF-β in mouse endometrium. |
2017 |
Eritja, N.; Felip, I.; Dosil, M.A.; Vigezzi, L.; Mirantes, C.; Yeramian, A.; Navaridas, R.; Santacana, M.; Llobet Navas, D.; Yoshimura, A.; Nomura, M.; Encinas, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer |
2017 |
Eritja, N.; Chen, B.J.; Rodríguez Barrueco, R.; Santacana, M.; Gatius, S.; Vidal, A.; Martí, M.D.; Ponce, J.; Bergadà, L.; Yeramian, A.; Encinas, M.; Ribera, J.; Reventós, J.; Boyd, J.; Villanueva, A. |
Article d'investigació |
Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition |
2016 |
Jonsson, M.; Ragnum, HB.; Julin, C.H.; Yeramian, A.; Clancy, T.; Frikstad, K.M.; Seierstad, T.; Stokke, T.; Matias Guiu, X.; Ree, A.H.; Flatmark, K.; Lyng, H. |
Article d'investigació |
2-phenylethynesulfonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels |
2016 |
Yeramian, A.; Vea, A.; Benítez, S.; Ribera, J.; Domingo, M.; Santacana, M.; Martinez, M.; Maiques, O.; Valls, J.; Dolcet, X.; Vilella, R.; Cabiscol, E.; Matias Guiu, X.; Marti, R.M. |
Article d'investigació |
Bioluminescence Imaging to Monitor the Effects of the Hsp90 Inhibitor NVP-AUY922 on NF-κB Pathway in Endometrial Cancer |
2016 |
Yeramian, A.; García, V.; Bergadà, L.; Domingo, M.; Santacana, M.; Valls, J.; Martinez Alonso, M.; Carceller, J.A.; Cussac, A.L.; Dolcet, X.; Matias Guiu, X. |
Article d'investigació |
Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism |
2016 |
Jove, M.; Gatius, S.; Yeramian, A.; Portero Otin, M.; Eritja, N.; Santacana, M.; Ruiz, M.; Pamplona, R.; Matias Guiu, X. |
Article d'investigació |
Antioxidants impair anti-tumoral effects of vorinostat, but not anti-neoplastic effects of vorinostat and caspase-8 downregulation |
2014 |
Bergadà L; Yeramian A; Sorolla A; Matias-Guiu X; Dolcet X. |
Article d'investigació |
Arginine transport is impaired in C57Bl/6 mouse macrophages as a result of a deletion in the promoter of Slc7a2 (CAT2), and susceptibility to Leishmania infection is reduced |
2013 |
Sans-Fons MG; Yeramian A; Pereira-Lopes S; Santamaría-Babi LF; Modolell M; Lloberas J; Celada A. |
Article d'investigació |
Long-term estradiol exposure is a direct mitogen for insulin/EGF-primed endometriaT cells and drives PTEN loss-induced hyperplasic growth |
2013 |
Eritja, N.; Mirantes, C.; Llobet, D.; Yeramian, A.; Bergadà, L.; Dosil, M.A.; Domingo, M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells |
2013 |
Bergadà, L.; Sorolla, A.; Yeramian, A.; Eritja, N.; Mirantes, C.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
New therapeutic targets in melanoma |
2012 |
Martí, R.M.; Sorolla, A.; Yeramian, A. |
Review |
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway |
2012 |
Yeramian, A.; Sorolla, A.; Dolcet, X.; Velasco, A.; Santacana, M.; Valls, J.; Abal, L.; Moreno, S.; Egido, R.; Casanova, J.M.; Puig, S.; Vilella, R.; Llombart Cussac, A.; Matias Guiu, X.; Marti, R.M. |
Article d'investigació |
Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells |
2012 |
Sorolla, A.; Yeramian, A.; Valls, J.; Dolcet, X.; Bergadà, L.; Llombart, Cussac, A.; Martí, R.M.; Matias Guiu, X. |
Article d'investigació |
Endometrial carcinoma: molecular alterations involved in tumor development and progression. |
2012 |
Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X. |
Article d'investigació |
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia. |
2012 |
Santacana, M.; Yeramian, A.; Velasco, A.; Bergada, L.; Gatius, S.; García, V.; Azueta, A.; Palacios, J.; Dolcet, X.; Oliva, E.; Matias Guiu, X. |
Article d'investigació |
Arginine and macrophage activation |
2012 |
Comalada, M.; Yeramian, A.; Modolell, M.; Lloberas, J.; Celada, A. |
Article d'investigació |
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels. |
2011 |
Llobet, D.; Eritja, N.; Domingo, M.; Bergada, L.; Mirantes, C.; Santacana, M.; Pallares, J.; Macià, A.; Yeramian, A.; Encinas, M.; Moreno Bueno, G.; Palacios, J.; Lewis, R.E.; Matias Guiu, X.; Dolcet, |
Article d'investigació |
Nuclear factor-kappa B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1 alpha independent manner |
2011 |
Yeramian, A.; Santacana, M.; Sorolla, A.; Llobet, D.; Encinas, M.; Velasco, A.; Bahi, N.; Eritja, N.; Domingo, M.; Oliva, E.; Dolcet, X.; Matias Guiu, X. |
Article d'investigació |
The multikinase inhibitor sorafenib induces apoptosis and sensitizes endometrial cancer cells to TRAIL by different mechanisms |
2010 |
Llobet, D.; Eritja, N.; Encinas, M.; Yeramian, A.; Pallares, J.; Sorolla, A.; Santacana, M.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma |
2010 |
Velasco, A.; Pallares, J.; Santacana, M.; Gatius, S.; Fernandez, M.; Domingo, M.; Valls, J.; Yeramian, A.; Encinas, M.; Dolcet, X.; Matias Guiu, X. |
Article d'investigació |
A novel 3D culture system of polarized epithelial cells to study endometrial carcinogenesis |
2010 |
Eritja N; Llobet D; Domingo M; Yeramian A; Matias-Guiu X; Dolcet X. |
Article d'investigació |
A review of the aplications of tissue microarray technology in understanding the molecular features of endometrial carcinoma |
2009 |
Pallarés, J.; Santacana, M.; Puente, S.; López, S.; Yeramian, A.; Eritja, N.; Sorolla, A.; Llobet, D.; Dolcet, X.; Matias Guiu, X. |
Review |
Molecular pathology of endometrial carcinoma; practical aspects from the diagnostic and therapeutical view points |
2009 |
Llobet, D.; Pallares, J.; Yeramian, A.; Santacana, M.; Eritja, N.; Velasco, A.; Dolcet, X.; Matias Guiu, X. |
Review |
Expression of somatostatin receptors in human melanoma cell lines: Effect of two different somatostatin analogues, octreotide and SOM230, on cell proliferation |
2009 |
Martinez Alonso, M.; Llecha, N.; Mayorga, M.E.; Sorolla, A.; Dolcet, X.; Sanmartin, V.; Abal, L.; Casanova, J.M.; Baradad, M.; Yeramian, A.; Egido, R.; Puig, S.; Vilella, R.; Matias Guiu, X.; Marti, R |
Article d'investigació |
CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation. |
2009 |
Pallares J; Llobet D; Santacana M; Eritja N; Velasco A; Cuevas D; Lopez S; Palomar-Asenjo V; Yeramian A; Dolcet X; Matias-Guiu X. |
Article d'investigació |
CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells |
2008 |
Llobet, D.; Eritja, N.; Encinas. M.; Llecha, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Gonzalez Tallada, F.J.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines |
2008 |
Sorolla, A.; Yeramian, A.; Dolcet, X.; Pérez de Santos, A.M.; Llobet, D.; Schoenenberger, J.A.; Casanova, J.M.; Soria, X.; Egido, R.; Llombart, A.; Vilella, R.; Matias Guiu, X.; Marti, R.M. |
Article d'investigació |
Targeted therapies in gynecologic cancers and melanoma |
2008 |
Ortega E; Marti RM; Yeramian A; Sorolla A; Dolcet X; Llobet D; Abal L;Santacana M; Pallares J; Llombart-Cussac A; Matias-Guiu X |
Review |
Deacetylase activity is required for STAT-5 dependent GM-CSF functional activity in macrophages and differentiation to dendritic cells. |
2008 |
Sebastián, C.; Serra, M.; Yeramian, A.; Serrat, N.; Lloberas, J.; Celada, A. |
Article d'investigació |
Antioxidants block proteasome inhibitor function in endometrial carcinoma cells |
2008 |
Llobet, D.; Eritja, N.; Encinas, M.; Sorolla, A.; Yeramian, A.; Schoenenberger, J.A.; Llombart Cussac, A.; Martí, R.M.; Matias Guiu, X.; Dolcet, X. |
Article d'investigació |
Loss of heterozygosity in endometrial carcinoma |
2008 |
Velasco A; Pallarés J; Santacana M; Yeramian A; Dolcet X; Eritja N; Puente S; Sorolla A; Llecha N; Matias-Guiu X |
Review |
Nuclear factor-kappa B activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma |
2008 |
Gallel, P.; Pallares, J.; Dolcet, X.; Llobet, D.; Eritja, N.; Santacana, M.; Yeramian, A.; Palomar Asenjo, V.; Lagarda, H.; Mauricio, D.; Encinas, M.; Matias Guiu, X. |
Article d'investigació |
Signalling by neurotrophins and hepatocyte growth factor regulates axon morphogenesis by differential beta-catenin phosphorylation |
2008 |
David, M.D.; Yeramian, A.; Duñach, M.; Llovera, M.; Cantí, C.; García de Herreros, A.; Comella, J.X.; Herreros, J. |
Article d'investigació |
Macrophages require distinct arginine catabolism and transport systems for proliferation and for activation |
2006 |
Yeramian A; Martin L; Arpa L; Bertran J; Soler C; McLeod C; Modolell M; Palacín M; Lloberas J; Celada A |
Article d'investigació |
Arginine transport via cationic amino acid transporter 2 plays a critical regulatory role in classical or alternative activation of macrophages. |
2006 |
Yeramian A; Martin L;Serrat N; Arpa L; Soler C;Bertran J; McLeod C; Palacín M; Modolell M;Lloberas J; Celada A. |
Article d'investigació |